Piśmiennictwo

1. Yazigi RA, Quintero CH, Salameh WA. Prolactin disorders. Fertil Steril. 1997;67(2):215-25.

2. Zgliczyński W, Zdunowski P. Hyperprolactinaemia – pitfalls in PRL assessment. Endokrynol Pol. 2005;56(6):980-5. Polish review.

3. Glezer A, Bronstein MD. Prolactinomas. Endocrinol Metab Clin North Am. 2015;44(1):71-8. doi: 10.1016/j.ecl.2014.11.003. Epub 2014 Nov 6.

4. Kasum M, Pavičić-Baldani D, Stanić P, et al. Importance of macroprolactinemia in hyperprolactinemia. Eur J Obstet Gynecol Reprod Biol. 2014;183:28-32. doi: 10.1016/j.ejogrb.2014.10.013. Epub 2014 Oct 20.

5. Fahie-Wilson M, Smith TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab. 2013 ;27(5):725-42. doi: 10.1016/j.beem.2013.07.002. Epub 2013 Aug 14.

6. Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273-88. doi: 10.1210/jc.2010-1692

7. Almalki MH, Alzahrani S, Alshahrani F, Alsherbeni S, Almoharib O, Aljohani N, Almagamsi A. Managing Prolactinomas during Pregnancy. Front Endocrinol (Lausanne). 2015;6:85. doi: 10.3389/fendo.2015.00085. eCollection 2015.

8. Molitch ME. Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma. Eur J Endocrinol. 2015 May;172(5):R205-13. doi: 10.1530/EJE-14-0848

9. Wang AT, Mullan RJ, Lane MA, et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis. Syst Rev. 2012;24:1:33. doi: 10.1186/2046-4053-1-33